Glycerin

Glycerin

SCHEMBL3948840

CCCCCCOCC.OCC(O)CO

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.71
HTT P42858 2/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
THRB P10828 1/20 0.52
MAPT P10636 1/20 0.52
PLA2G2C Q5R387 1/20 0.49
LPAR5 Q9H1C0 1/20 0.46
SPHK1 Q9NYA1 1/20 0.44
KDM4E B2RXH2 1/20 0.44
DUSP3 P51452 1/20 0.44
LMNA P02545 1/20 0.44
CES2 O00748 2/20 0.44
TSHR P16473 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycerin SCHEMBL27365614 0.94 USP2 (0.69) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL3680035 0.94 USP2 (0.69) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL2840855 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL16289663 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL4335281 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL722452 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL466711 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL3092973 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL2411393 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB
Glycerin SCHEMBL18140350 0.91 USP2 (0.77) USP2HTTMEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052263-A1 CLEANING COMPOSITIONS EMPLOYING EXTENDED CHAIN ANIONIC SURFACTANTS ECOLAB USA INC. 2024-02-15 US claimed
US-11814604-B2 Cleaning compositions employing extended chain anionic surfactants ECOLAB USA INC. (US) 2023-11-14 US claimed
US-20220213411-A1 CLEANING COMPOSITIONS EMPLOYING EXTENDED CHAIN ANIONIC SURFACTANTS ECOLAB USA INC. 2022-07-07 US claimed
US-20210108155-A1 CLEANING COMPOSITIONS EMPLOYING EXTENDED CHAIN ANIONIC SURFACTANTS ECOLAB USA INC. 2021-04-15 US claimed
US-20190203156-A1 CLEANING COMPOSITIONS EMPLOYING EXTENDED CHAIN ANIONIC SURFACTANTS ECOLAB USA INC. 2019-07-04 US claimed
US-10273433-B2 Cleaning compositions employing extended chain anionic surfactants ECOLAB USA INC. (US) 2019-04-30 US claimed
US-20180208879-A1 CLEANING COMPOSITIONS EMPLOYING EXTENDED CHAIN ANIONIC SURFACTANTS ECOLAB USA INC. 2018-07-26 US claimed
CN-114786646-A Method for producing solid powder composite, and solid powder composite 株式会社资生堂 2022-07-22 CN disclosed
US-10709653-B2 Cosmetic compositions comprising spiculisporic acid and at least one sulfate and/or sulfonate surfactant L'OREAL (FR) 2020-07-14 US disclosed
US-10646427-B2 Cosmetic compositions comprising spiculisporic acid and an ester of fatty acid and(poly)glycerol optionally polyoxyalkylenated L'OREAL (FR) 2020-05-12 US disclosed
EP-3515398-A1 METHODS FOR REDUCING SWEAT AND/OR BODY ODOUR USING SPECIFIC ACIDS OR DERIVATIVES THEREOF Henkel AG & Co. KGaA (DE) 2019-07-31 EP disclosed
EP-3065830-B1 COSMETIC COMPOSITIONS COMPRISING SPICULISPORIC ACID AND AN ESTER OF FATTY ACID OREAL (FR) 2018-05-09 EP disclosed
EP-3065696-B1 COSMETIC COMPOSITIONS COMPRISING SPICULISPORIC ACID AND AT LEAST ONE SULFATE AND/OR SULFONATE SURFACTANT OREAL (FR) 2018-02-21 EP disclosed
WO-2009074409-A1 S-TRIAZINE COMPOUNDS CONTAINING ONE AMINOSILOXANE GROUP AND TWO PARTICULAR PARA-AMINOBENZALMALONATE GROUPS; COSMETIC COMPOSITIONS CONTAINING SAID DERIVATIVES; USES OF SAID S-TRIAZINE DERIVATIVES L'OREAL (FR) 2009-06-18 WO disclosed
CN-101317812-A Stable, low viscosity cosmetic compounds containing esterquat and/or dialkylquat EVONIK GOLDSCHMIDT GMBH (DE) 2008-12-10 CN disclosed
CN-101155842-A Cationic polymers as thickeners for aqueous and alcoholic compositions BASF AG (DE) 2008-04-02 CN disclosed
US-20070219107-A1 Sheet-Like Body Cleaning Material KAO CORPORATION (JP) 2007-09-20 US disclosed
CN-1793243-A Structure modified titanium dioxides DEGUSSA (DE) 2006-06-28 CN disclosed
US-6667044-B1 Water-in-oil microemulsion in form of gel comprising oily phase composed of constituents of low volatility, and discontinuous aqueous phase comprising various emulsifiers, in which droplets are joined to one another by crosslinking BEIERSDORF AG (DE) 2003-12-23 US disclosed
US-5591442-A MIXTURE OF ALIPHATIC ALCOHOL AND GLYCEROL 1-ALKYL ETHER AS ANTISEPTICS RECKITT & COLMAN INC. (US) 1997-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10709653-B2 Cosmetic compositions comprising spiculisporic acid and at least one sulfate and/or sulfonate surfactant SUCLG1, SUCNR1, SCLY USP2 3483/4885HTT 2901/4885MEN1 441/4885
US-10646427-B2 Cosmetic compositions comprising spiculisporic acid and an ester of fatty acid and(poly)glycerol optionally polyoxyalkylenated SGPL1, CUTA, EBP USP2 2205/4885HTT 823/4885MEN1 3719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.